Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ERYTECH Pharma S.A. Regulatory Filings 2021

Aug 5, 2021

1295_dva_2021-08-05_e29de397-3642-4919-9393-61efe3371b9f.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Monthly information related to total number of voting rights and shares composing the share capital – July 30, 2021.

Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France

Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP) Website : www.erytech.com

Date Total of shares composing the
share capital
Total of brut (1) voting
rights
Total of net (2) voting rights
December 31, 2020 20 057 562 21 592 598 21 590 098
January 31, 2021 20 395 482 21 930 518 21 928 018
February 28, 2021 21 139 668 22 668 705 22 666 205
March 31, 2021 21 619 894 23 149 446 23 146 946
April 30, 2021 21 646 489 23 176 061 23 173 561
May 31, 2021 26 048 225 27 569 797 27 567 297
June 30, 2021 26 412 389 27 934 088 27 931 588
July 30, 2021 27 320 457 28 844 656 28 842 156

(1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.

(2) Without treasury shares.